The right to withdraw from controlled human infection studies: Justifications and avoidance.

The right to withdraw from research without penalty is well established around the world. However, it has been challenged in some corners of bioethics based on concerns about various harms—to participants, to scientific integrity, and to research bystanders—that may stem from withdrawal. These conce...

Descripción completa

Detalles Bibliográficos
Publicado en:Bioethics Vol. 34; no. 8; pp. 833 - 849
Autor principal: Fernandez Lynch, Holly
Formato: Artículo
Publicado: Wiley-Blackwell Oct2020
Materias:
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=146468820&site=ehost-live
header:
  @attributes:
    shortDbName: ssf
    uiTerm: 146468820
    longDbName: Social Sciences Full Text (H.W. Wilson)
    uiTag: AN
  controlInfo:
    bkinfo:
    jinfo:
      jid:
        02699702
        6PJ
      jtl: Bioethics
      issn: 02699702
      maglogo: Y
    pubinfo:
      dt: Oct2020
      vid: 34
      iid: 8
      pid: 480
      pub: Wiley-Blackwell
    artinfo:
      ui:
        146468820
        10.1111/bioe.12704
      ppf: 833
      ppct: 16
      formats:
      tig:
        atl: The right to withdraw from controlled human infection studies: Justifications and avoidance.
      aug:
        au: Fernandez Lynch, Holly
        affil:
          Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia Pennsylvania
          Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia Pennsylvania
      su:
        Bioethics
        Human rights
        Informed consent (Medical law)
        Punishment
        Human research subjects
        Harm reduction
      sug:
        subj:
          Bioethics
          Human rights
          Informed consent (Medical law)
          Punishment
          Human research subjects
          Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
          Harm reduction
      keyword:
        bystander
        completion bonus
        consent
        controlled human infection study
        human challenge trial
        penalty
        right to withdraw
        bystander
        completion bonus
        consent
        controlled human infection study
        human challenge trial
        penalty
        right to withdraw
      ab: The right to withdraw from research without penalty is well established around the world. However, it has been challenged in some corners of bioethics based on concerns about various harms—to participants, to scientific integrity, and to research bystanders—that may stem from withdrawal. These concerns have become particularly salient in emerging debates about the ethics of controlled human infection (CHI) studies in which participants are intentionally infected with pathogens, often in inpatient settings with extensive follow‐up. In this article, I provide support for preserving the right to withdraw from research without penalty and demonstrate that it is also typically justified in the specific context of CHI studies. The right is well aligned with individual freedoms outside the research setting, where autonomous individuals are permitted to engage in behaviors that will foreseeably cause them harm; where they cannot be compelled to satisfy contracts for their services, nor penalized for failure to do so; and where their behavior is not constrained by public health authorities except in extreme circumstances. These freedoms are supported by U.S. law, as well as by ethical analysis that is more globally relevant. The problems associated with the right to withdraw, however, remain. The best approach to addressing them is not to restrict the right but rather to avoid initiating research when withdrawal would be especially problematic. If research proceeds, steps can still be taken to minimize participant withdrawal without infringing the right. Investigators can avoid participant surprise through informed consent focused on a study's most burdensome aspects and promote study completion through financial incentives. Should participants nonetheless seek to withdraw, investigators may attempt to persuade them not to do so by encouraging consideration of the range of potential harms that may result. Researchers conducting CHI studies and other research from which withdrawal might be especially problematic should prepare for the possibility of participant withdrawal, respect participant requests to withdraw without penalty, and incorporate various measures to avoid such requests.
      pubtype: Academic Journal
      doctype: Article
      src: R
    language: English
    refInfo:
    copyright:
      @attributes:
        flag: N
    holdings:
      @attributes:
        islocal: N